Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03367923 · ClinicalTrials.gov registry record · Phase 2
Health and Recovery Program in Increasing Physical Activity Level in Stage IA-IIIA Endometrial Cancer Survivors
A Phase 2 study of Endometrial Carcinoma and Cancer Survivor, sponsored by Stanford University.
- Completed
- Registry status
- Phase 2
- Development phase
- 47
- Enrollment target
- 2
- Study locations
NCT03367923 is a Phase 2 study of Endometrial Carcinoma and Cancer Survivor that has completed, run by Stanford University. The registered enrollment target is 47 participants, below the 389-participant average among 27 other Endometrial Carcinoma trials with a reported enrollment target (88% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT03367923, a Phase 2 study of Endometrial Carcinoma and Cancer Survivor, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 47 participants
- Enrollment target
- 2
- Study locations
Study Summary
This randomized phase II trial studies how well a health and recovery program works in increasing physical activity level in stage IA-IIIA endometrial cancer survivors. Health and recovery program which includes exercise counseling, Fitbit tracker, and phone or email/text communication may increase the level of physical activity in endometrial cancer survivors and promote and maintain behavior change at a lower cost.
Conditions Studied
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Questionnaire Administration
- OTHER Communication Intervention
- OTHER Counseling
- OTHER Fitbit tracker
Study Locations (2)
California
- Stanford University, School of Medicine - Palo Alto
- Stanford Cancer Center South Bay - San Jose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2017-12-01 |
| Est. Completion | 2020-03-25 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03367923
The ClinicalTrials.gov registry entry for NCT03367923 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 389-participant average among 27 other Endometrial Carcinoma trials with a reported enrollment target (88% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Endometrial Carcinoma appearing as the primary indexed condition, and to 5 interventions - of which Quality-of-Life Assessment is the first listed.
NCT03367923 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03367923 about?
NCT03367923 is a clinical study titled "Health and Recovery Program in Increasing Physical Activity Level in Stage IA-IIIA Endometrial Cancer Survivors". This randomized phase II trial studies how well a health and recovery program works in increasing physical activity level in stage IA-IIIA endometrial cancer survivors. Health and recovery program which includes exercise counseling, Fitbit tracker, and phone or email/text communication may increase ...
What is the current status of trial NCT03367923?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 47 participants. The study started on 2017-12-01. Estimated completion is 2020-03-25.
What conditions does trial NCT03367923 study?
This clinical trial studies the following conditions: Endometrial Carcinoma, Cancer Survivor, Stage I Uterine Corpus Cancer AJCC v7, Stage IA Uterine Corpus Cancer AJCC v7, Stage IB Uterine Corpus Cancer AJCC v7.
What interventions are being tested in trial NCT03367923?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Communication Intervention (OTHER), Counseling (OTHER), Fitbit tracker (OTHER).
Who is sponsoring clinical trial NCT03367923?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03367923 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometrial Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
RECRUITING · Phase 2
-
Megestrol Acetate Compared With Megestrol Acetate and Metformin to Prevent Endometrial Cancer
ACTIVE NOT RECRUITING · Phase 2
-
Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy
ACTIVE NOT RECRUITING · Phase 2
-
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
ACTIVE NOT RECRUITING · Phase 2
-
A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma
ACTIVE NOT RECRUITING · Phase 2
-
A Study of Nivolumab in Selected Uterine Cancer Patients
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.